Moneycontrol PRO
Upcoming Webinar:Innovate Your Future at India Inc. on the Move on August 26 and 27, 2021 at 10am, with Rockwell Automation

Unichem Laboratories receives ANDA approval from USFDA for Piroxicam capsules

Unichem Laboratories is pleased to announce that it has received ANDA approval from the United States Food and Drug Administration (USFDA) for Piroxicam Capsules USP 10mg

April 17, 2017 / 11:29 AM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More
Unichem Laboratories Limited is pleased to announce that it has received ANDA approval from the United States Food and Drug Administration (USFDA) for Piroxicam Capsules USP 10mg & 20mg, which are therapeutically equivalent to Feldene Capsules 10mg & 20mg of Pfizer, Inc. Piroxicam is a nonsteroidal anti-inflammatory drug (NSAID) indicated for relief of the signs and symptoms of osteoarthritis (OA) and rheumatoid arthritis (RA). For the relief of rheumatoid arthritis and osteoarthritis, the dosage is 20 mg given orally once daily. If desired, the daily dose may be divided. Usually lowest effective dosage for the shortest duration, consistent with individual patient treatment goals is recommended. The product will be commercialized from Unichem's Goa plant. Active Pharmaceutical Ingredient will also be made in house at Roha API Plant.Source : BSE
first published: Apr 17, 2017 11:29 am

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark